Fact CheckerSign in

NCT07112274Completed

Empagliflozin on Patients With Preserved Heart Failure

Effect of Empagliflozin on Cardiac Remodeling in Non Diabetic Patients With Preserved Heart Failure

Source: ClinicalTrials.gov · Last updated 3 Dec 2025

Brief summary (registry, in English)

The proposed research in this application will investigate the effect of empagliflozin on cardiac remodeling in patients with heart failure with preserved ejection fraction.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
1 Aug 2025
Start date
1 Oct 2022
Primary completion date
30 Jun 2025
Lead sponsor
Damanhour University
NCT number
NCT07112274

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 1 Oct 2022 to the primary completion date, 30 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inculsion
  • Cardiac patients who diagnosed with HFpEF, EF more than 50 %.
  • Patients should have basically normal liver and kidney functions, normal coagulation, and have no serious auditory, visual or central nervous system diseases.
  • Patients with no history of immune system disease.
    • Exclusion
  • Patients with declined baseline creatinine clearance below 60 ml/min
  • Patients diagnosed with acute liver failure, AKI, hypoglycemia.
  • Allergy to the ingredients which will be used in this study
  • Patients with Diabetic ketoacidosis or non ketotic hyperosmolar hyperglycemia
  • Severe hepatic disease.

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rehab Hussein Werida
Coordinator of this site? Confirm its status
DamanhūrEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.